Table of Contents
ISRN Pathology
Volume 2011 (2011), Article ID 680890, 6 pages
http://dx.doi.org/10.5402/2011/680890
Research Article

Expression of Phosphatase Regenerating Liver-1 in Esophageal Squamous Cell Carcinoma Associated with Metastasis

1Department of Pathology, The First Affiliated Hospital, Zhengzhou University School of Medicine, Zhengzhou 450052, China
2Jdxpath Laboratory, Collegeville, PA 19426-1889, USA
3Institute of Molecular and Cell Biology, Proteos, Singapore 138673

Received 24 March 2011; Accepted 20 April 2011

Academic Editors: B. Azadeh and A. Gocht

Copyright © 2011 Yuqiong Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. J. Ribeiro, M. Posner, R. A. Safatle et al., “Risk factors for squamous cell carcinoma of the oesophagus,” British Journal of Surgery, vol. 83, no. 9, pp. 1174–1185, 1996. View at Google Scholar · View at Scopus
  2. L. D. Li and F. Z. Lu, “Survey on the death of malignant tumors in China,” China Cancer, vol. 5, pp. 3–7, 1996. View at Google Scholar
  3. H. E. Gabbert, T. Shimoda, P. Hainaut et al., “Squamous cell carcinoma of the esophagus,” in Tumors of the Digestive System, S. R. Hamilton and L. A. Aaltonen, Eds., pp. 11–19, IARC Press, Lyon, France, 2000, World Health Organization Classification of Tumors. View at Google Scholar
  4. X. Chen and C. S. Yang, “Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention,” Carcinogenesis, vol. 22, no. 8, pp. 1119–1129, 2001. View at Google Scholar · View at Scopus
  5. T. Hunter, “Signaling—2000 and beyond,” Cell, vol. 100, no. 1, pp. 113–127, 2000. View at Google Scholar · View at Scopus
  6. M. A. Lyon, A. P. Ducruet, P. Wipf et al., “Dual-specificity phosphatases as targets for antineoplastic agents,” Nature Reviews Drug Discovery, vol. 1, no. 12, pp. 961–976, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. B. T. Hoffman, M. R. Nelson, K. Burdick et al., “Protein tyrosine phosphatases: strategies for distinguishing proteins in a family containing multiple drug targets and anti-targets,” Current Pharmaceutical Design, vol. 10, no. 10, pp. 1161–1181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Cates, R. L. Michael, K. R. Stayrook et al., “Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases,” Cancer Letters, vol. 110, no. 1-2, pp. 49–55, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Zeng, W. Hong, and Y. H. Tan, “Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1,” Biochemical and Biophysical Research Communications, vol. 244, no. 2, pp. 421–427, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Diamond, D. E. Cressman, T. M. Laz et al., “PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth,” Molecular and Cellular Biology, vol. 14, no. 6, pp. 3752–3762, 1994. View at Google Scholar · View at Scopus
  11. W. F. Matter, T. Estridge, C. Zhang et al., “Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling,” Biochemical and Biophysical Research Communications, vol. 283, no. 5, pp. 1061–1068, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wang, C. E. Kirby, and R. Herbst, “The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis,” Journal of Biological Chemistry, vol. 277, no. 48, pp. 46659–46668, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. U. A. Miskad, S. Semba, H. Kato et al., “Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis,” Pathobiology, vol. 71, no. 4, pp. 176–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Wu, H. Zeng, X. Zhang et al., “Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells,” American Journal of Pathology, vol. 164, no. 6, pp. 2039–2054, 2004. View at Google Scholar · View at Scopus
  15. F. Polato, A. Codegoni, R. Fruscio et al., “PRL-3 phosphatase is implicated in ovarian cancer growth,” Clinical Cancer Research, vol. 11, no. 19 I, pp. 6835–6839, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Zhao, Z. G. Zhou, W. Z. Lei et al., “Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma,” Zhonghua Wei Chang Wai Ke Za Zhi, vol. 8, no. 3, pp. 237–240, 2005. View at Google Scholar · View at Scopus
  17. H. Kato, S. Semba, U. A. Miskad et al., “High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases,” Clinical Cancer Research, vol. 10, no. 21, pp. 7318–7328, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Ren, B. Jiang, X. Xing et al., “Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer,” Pathology and Oncology Research, vol. 15, no. 4, pp. 555–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Dai, A. P. Lu, C. C. Shou et al., “Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer,” World Journal of Gastroenterology, vol. 15, no. 12, pp. 1499–1505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Xu, M. Zhu, S. Zhang et al., “Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma,” Pathology and Oncology Research, vol. 16, no. 2, pp. 169–175, 2010. View at Publisher · View at Google Scholar
  21. J. Zhou, S. Wang, J. Lu et al., “Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma,” International Journal of Cancer, vol. 124, no. 8, pp. 1879–1886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Ooki, K. Yamashita, S. Kikuchi et al., “Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer,” Oncology Reports, vol. 21, no. 6, pp. 1467–1475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. T. Hao, X. H. Zhang, Y. F. Pan et al., “Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 9, pp. 1349–1357, 2010. View at Publisher · View at Google Scholar
  24. Y. Q. Liu, H. X. Li, X. Lou et al., “Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma,” Archives of Pathology and Laboratory Medicine, vol. 132, no. 8, pp. 1307–1312, 2008. View at Google Scholar · View at Scopus
  25. W. Kong, G. P. Swain, S. Li et al., “PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues,” American Journal of Physiology, vol. 279, no. 3, pp. G613–G621, 2000. View at Google Scholar · View at Scopus
  26. J. Li, K. Guo, V. W Koh et al., “Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases,” Clinical Cancer Research, vol. 11, no. 6, pp. 2195–2204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Peng, J. Ning, L. Meng et al., “The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer,” Journal of Cancer Research and Clinical Oncology, vol. 130, no. 9, pp. 521–526, 2004. View at Google Scholar · View at Scopus
  28. Q. Zeng, J. M. Dong, K. Guo et al., “PRL-3 and PRL-1 promote cell migration, invasion, and metastasis,” Cancer Research, vol. 63, no. 11, pp. 2716–2722, 2003. View at Google Scholar · View at Scopus
  29. H. Han, D. J. Bearss, L. W. Browne et al., “Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray,” Cancer Research, vol. 62, no. 10, pp. 2890–2896, 2002. View at Google Scholar · View at Scopus
  30. Q. Wang, D. I. Holmes, S. M. Powell et al., “Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene,” Cancer Letters, vol. 175, no. 1, pp. 63–69, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Harnden, I. Eardley, A. D. Joyce et al., “Cytokeratin 20 as an objective marker of urothelial dysplasia,” British Journal of Urology, vol. 78, no. 6, pp. 870–875, 1996. View at Google Scholar · View at Scopus
  32. S. Saha, A. Bardelli, P. Buckhaults et al., “A phosphatase associated with metastasis of colorectal cancer,” Science, vol. 294, no. 5545, pp. 1343–1346, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Bardelli, S. Saha, J. A. Sager et al., “PRL-3 expression in metastatic cancers,” Clinical Cancer Research, vol. 9, no. 15, pp. 5607–5615, 2003. View at Google Scholar · View at Scopus
  34. I. Radke, M. Götte, C. Kersting et al., “Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer,” British Journal of Cancer, vol. 95, no. 3, pp. 347–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. U. A. Miskad, S. Semba, S. Kato et al., “High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study,” Virchows Archiv, vol. 450, no. 3, pp. 303–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Zeng, X. Si, H. Horstmann et al., “Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome,” Journal of Biological Chemistry, vol. 275, no. 28, pp. 21444–21452, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. T. E. Buffart, J. Coffa, M. A. Hermsen et al., “DNA copy number changes at 8q11-24 in metastasized colorectal cancer,” Cellular Oncology, vol. 27, no. 1, pp. 57–65, 2005. View at Google Scholar · View at Scopus
  38. M. K. Pathak, D. Dhawan, D. J. Lindner et al., “Pentamidine is an inhibitor of PRL phosphatases with anticancer activity,” Molecular Cancer Therapeutics, vol. 1, no. 14, pp. 1255–1264, 2002. View at Google Scholar · View at Scopus